Bruker Corporation announced the launch of the timsOmni™ system, a transformative new timsTOF-based mass spectrometer designed for scientific, drug discovery, and clinical researchers, as well as for advanced QC on biologics, offering deep structural insights into the functional or pathological proteoforms or oligonucleotides.
Bruker Corporation announced significant further advances in ultra-high sensitivity 4D-Proteomics™ with the introduction of the timsUltra AIP mass spectrometer. Its innovative, breakthrough Athena Ion Processor (AIP) technology further boosts the extreme sensitivity of timsTOF Ultra PASEF® methods for key biological and clinical research problems with very low sample amounts.
TheraLight, LLC, a leader in whole-body Photobiomodulation, proudly announces the launch of the TheraLight 360i, a next-generation whole body therapy system that uniquely integrates three advanced, non-invasive therapeutic modalities: Photobiomodulation (PBM), Pulsed Electromagnetic Field (PEMF) Therapy, and Acoustic Resonance Therapy (ART).
BD (Becton, Dickinson and Company) a leading global medical technology company, launched the world's first cell analyzer featuring breakthrough spectral and real-time cell imaging technologies, enabling more researchers across a wider range of applications to uncover deeper insights and dynamics from cells once invisible in flow cytometry experiments – with increased ease and throughput.
Viome Life Sciences, the leader in AI-powered, RNA-driven molecular diagnostics and precision nutrition, today launched its most transformative consumer product, redefining how individuals understand, track, and improve their health through evolving biological insights.